Average Co-Inventor Count = 4.53
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Glaxo Group Limited (15 from 1,168 patents)
2. Smithkline Beecham Corporation (7 from 2,198 patents)
3. Glaxosmithkline Intellectual Property Development Limited (3 from 230 patents)
4. Glaxosmithkline LLC (1 from 356 patents)
5. Smithkline Beechum P.l.c. (1 from 4 patents)
27 patents:
1. 10815218 - Benzoimidazole derivatives as PAD4 inhibitors
2. 10407407 - Benzoimidazole derivatives as PAD4 inhibitors
3. 10039755 - 2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors
4. 9833449 - 2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors
5. 9624219 - Compound (S) and (R)-N-(2-fluoropyridin-4-yl)-3-methyl-2-(5-methyl-2,4-dioxo-1,2-dihydropyrido[3,4-d]pyrimidin-3(4H)-yl)butanamide and use
6. 9518054 - 2-(azaindol-2-yl) benz imidazoles as PAD4 inhibitors
7. 9447074 - Compounds
8. 9127003 - 2-(azaindol-2-yl)benzimidazoles as PAD4 inhibitors
9. 8993560 - Compounds
10. 8697725 - Tetrahydroquinoline derivatives and their pharmaceutical use
11. 8691747 - Method of treatment based on ATAD2 inhibitors
12. 8633319 - 7-(1H-pyrazol-4-yl)-1,6-naphthyridine compounds as Syk inhibitors
13. 8207331 - Benzazepine derivatives for the treatment of neurological disorders
14. 7888347 - Pyrazolo [3,4-D]azepine derivatives as histamine H3 antagonists
15. 7799773 - Benzazepine derivatives for the treatment of neurological disorders